Skip to main content
. 2020 Jun 29;219(9):e202003091. doi: 10.1083/jcb.202003091

Figure 2.

Figure 2.

Branched actin networks in growth cones of rat hippocampal neurons treated with low concentrations of actin polymerization inhibitors. (A–D) DIV2 neurons treated for the last 24 h with 5 µM LatB and stained with DM1α antibody against α-tubulin and secondary antibody conjugated to 18-nm colloidal gold. Boxed regions in A and B are enlarged in B and C, respectively. Blue arrows in B indicate accumulations of branched actin networks that appear to emerge from microtubules. (E–H) DIV3 rat hippocampal neurons treated for the last 24 h with 1 µM CytoD and stained with DM1α antibody and 12-nm colloidal gold-conjugated secondary antibody. Boxed regions in E are enlarged in F and G. Inset in H shows an overview of the growth cone; the boxed region corresponds to the main panel. (I) DIV2 rat hippocampal neuron treated for the last 24 h with 1 µM CytoD without immunogold labeling. Color coding: blue, branched actin filaments that appear to emerge from microtubules; red, microtubules; yellow, immunogold. Scale bars, 2 µm (A and inset in H), 1 µm (B and E), 100 nm (C and F–I), and 200 nm (D).